Christianson, H.L.; Sabry, A.A.; Sous, J.E.G.; Adams, J.H.; Hoppe, K.K.; Antony, K.M.
Outcomes of Neonates Exposed to Buprenorphine versus Methadone in Utero: A Systematic Review and Meta-Analysis of Safety in the Fetus and Neonate. Reprod. Med. 2021, 2, 185-194.
https://doi.org/10.3390/reprodmed2040019
AMA Style
Christianson HL, Sabry AA, Sous JEG, Adams JH, Hoppe KK, Antony KM.
Outcomes of Neonates Exposed to Buprenorphine versus Methadone in Utero: A Systematic Review and Meta-Analysis of Safety in the Fetus and Neonate. Reproductive Medicine. 2021; 2(4):185-194.
https://doi.org/10.3390/reprodmed2040019
Chicago/Turabian Style
Christianson, Hannah L., Alea A. Sabry, Jinan E. G. Sous, Jacquelyn H. Adams, Kara K. Hoppe, and Kathleen M. Antony.
2021. "Outcomes of Neonates Exposed to Buprenorphine versus Methadone in Utero: A Systematic Review and Meta-Analysis of Safety in the Fetus and Neonate" Reproductive Medicine 2, no. 4: 185-194.
https://doi.org/10.3390/reprodmed2040019
APA Style
Christianson, H. L., Sabry, A. A., Sous, J. E. G., Adams, J. H., Hoppe, K. K., & Antony, K. M.
(2021). Outcomes of Neonates Exposed to Buprenorphine versus Methadone in Utero: A Systematic Review and Meta-Analysis of Safety in the Fetus and Neonate. Reproductive Medicine, 2(4), 185-194.
https://doi.org/10.3390/reprodmed2040019
